Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement

A legfontosabb adatok

Ki végzi
Chinese Academy of Medical Sciences, Fuwai Hospital
Hol
Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
1000 fő, tervezett
Kezdés
2022. jan. 1.
Várható befejezés
2026. dec. 31.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • TAVR Aspirin and clopidogrel
A regiszteradat frissítve
2026. február 5.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt
A regiszter összes feltétele (11)A regiszter feltételeinek elrejtése

Ki vehet részt

  • Age ≥18 years at the time of transcatheter aortic valve replacement (TAVR). Diagnosis of severe aortic stenosis based on current guideline-recommended echocardiographic criteria
  • Undergoing transcatheter aortic valve replacement (TAVR) as part of routine clinical care
  • Availability of baseline electrocardiographic assessment, including ambulatory electrocardiographic monitoring for evaluation of premature ventricular contraction (PVC) burden
  • Completion of post-procedural rhythm follow-up, including ambulatory electrocardiographic monitoring at 12 months after TAVR
  • Ability to provide informed consent or availability of legally authorized consent, as required by the institutional review board

Ki nem vehet részt

  • Presence of a permanent pacemaker or implantable cardioverter-defibrillator prior to TAVR
  • Receipt of catheter ablation for atrial or ventricular arrhythmias before TAVR or during the follow-up period
  • Absence of premature ventricular contractions at baseline (PVC burden = 0), as PVC response cannot be meaningfully assessed in this population
  • Death occurring during the index hospitalization or before completion of rhythm follow-up
  • Inability to complete scheduled electrocardiographic or ambulatory rhythm assessments during follow-up
  • Missing or incomplete key electrocardiographic, echocardiographic, or follow-up data required for outcome assessment

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The TAVR-ELECTRO Registry (Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement) is a single-center, observational cohort study designed to systematically evaluate the occurrence, temporal evolution, and determinants of cardiac arrhythmias following transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis.

A teljes eredeti leírásKevesebb

This registry retrospectively enrolls consecutive patients undergoing TAVR at Fuwai Hospital, Chinese Academy of Medical Sciences, and collects comprehensive clinical, echocardiographic, electrocardiographic, and procedural data. Particular emphasis is placed on post-procedural electrophysiological outcomes, including ventricular arrhythmias, atrial arrhythmias, and conduction disturbances. Serial rhythm assessments using standard electrocardiography and ambulatory electrocardiographic monitoring are performed during follow-up to characterize arrhythmic burden and its dynamic changes over time.

The primary objective of the TAVR-ELECTRO Registry is to identify clinical, haemodynamic, and procedural factors associated with post-TAVR arrhythmic outcomes and recovery patterns, thereby improving the understanding of electrophysiological remodeling after TAVR and informing post-procedural risk stratification and management strategies.

A vizsgált kezelések

  • TAVR Aspirin and clopidogrel

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. február 5.